Status:
WITHDRAWN
Objective Measurement of Hearing Aid Benefit
Lead Sponsor:
University of Maryland, College Park
Conditions:
Auditory Perceptual Disorders
Age-related Hearing Loss
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Hearing loss is a critical health concern in the rapidly aging population, affecting approximately 22 million older individuals in the United States. Yet, only 30% of individuals who would benefit fro...
Detailed Description
Hearing loss is among the top three major health conditions in older adults and has been identified as a major modifiable risk factor for dementia. It is therefore imperative that older adults receive...
Eligibility Criteria
Inclusion
- Aims 1 and 2 age ranges: 18-35 and 60-75
- Aim 3 age range: 50 to 85
- Aims 1 and 2 hearing levels: 1) Normal hearing thresholds defined as pure-tone thresholds ≤ 20 decibel (dB) hearing level (HL) from 125 to 4000 Hz and ≤ 30 dB HL at 6000 and 8000 Hz bilaterally, or 2) Mild to moderate sensorineural hearing loss defined as thresholds within 5 dB of 30 dB HL at 500 Hz, 50 dB HL at 1000 and 2000 Hz, and 60 dB HL at 4000 Hz.
- Aim 3 hearing level: Symmetric hearing thresholds with no interaural difference ≥ 15 dB HL at ≥ 2 frequencies.
- Intelligent Quotients ≥ 85 based on the Wechsler Abbreviated Scale of Intelligence (Psychological Corp., New York)
- Scores ≥ 24 on the Montreal Cognitive Assessment
Exclusion
- Neurological disorders
- Middle ear pathology
- Nonnative English speakers
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2027
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04431622
Start Date
June 1 2022
End Date
August 1 2027
Last Update
May 23 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.